CONZIP

LOE Approaching

tramadol hydrochloride

NDAORALCAPSULE, EXTENDED RELEASE
Approved
May 2010
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
15

Mechanism of Action

Extended-Release Capsules contain tramadol, an opioid agonist, and an inhibitor of reuptake of norepinephrine and serotonin. Although its mode of action is not completely understood, from animal tests, at least two complementary mechanisms appear applicable: binding of parent and M1 metabolite to…

Clinical Trials (5)

NCT03803371Phase 4Completed

Bioequivalence Study of Tramadol Hydrochloride /Paracetamol Tablets Versus Ultracet Tablets

Started Mar 2019
60 enrolled
Healthy
NCT02307864Phase 1Completed

Study to Evaluate the Effects of Tramadol Hydrochloride on Cardiac Repolarization in Healthy Participants

Started Dec 2014
68 enrolled
Healthy
NCT01947920Phase 1Completed

A Dose Ranging Escalation Study of Tramadol Hydrochloride in Healthy Volunteers

Started Aug 2013
30 enrolled
Healthy
NCT01819805N/ACompleted

A Study to Assess the Improvement of Pain and Health-Related Quality of Life in Patients With Chronic Non-Malignant Pain Taking Tramadol Hydrochloride and Acetaminophen

Started Sep 2011
1,065 enrolled
Chronic Pain
NCT01814878Phase 3Completed

A Study Comparing the Effectiveness and Safety of Extended Release (ER) Tramadol Hydrochloride (HCl)/Acetaminophen With Immediate Release (IR) Tramadol HCl/Acetaminophen in Participants With Moderate to Severe Postoperative Pain

Started Nov 2009
320 enrolled
Pain, Postoperative